EBITDA at other companies
Other financials
Where this comes from
Calculated from Arbutus Biopharma Corporation’s reported figures.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's EBITDA?
- Arbutus Biopharma Corporation (ABUS) reported EBITDA of $168.92M in Q1 2026.
- How has Arbutus Biopharma Corporation's EBITDA changed year-over-year?
- Arbutus Biopharma Corporation's EBITDA increased by 765.8% year-over-year, from -$25.37M to $168.92M.
- What is the long-term trend for Arbutus Biopharma Corporation's EBITDA?
- Over 4 years (2021 to 2025), Arbutus Biopharma Corporation's EBITDA has grown at a -14.9% compound annual growth rate (CAGR), from -$71.76M to -$37.72M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.